Medical Developments International Limited
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more
Medical Developments International Limited (MDDVF) - Total Assets
Latest total assets as of June 2025: $66.40 Million USD
Based on the latest financial reports, Medical Developments International Limited (MDDVF) holds total assets worth $66.40 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medical Developments International Limited - Total Assets Trend (2003–2025)
This chart illustrates how Medical Developments International Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medical Developments International Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Medical Developments International Limited's total assets of $66.40 Million consist of 53.5% current assets and 46.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.9% |
| Accounts Receivable | $7.51 Million | 11.3% |
| Inventory | $9.45 Million | 14.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.06 Million | 3.1% |
| Goodwill | $3.81 Million | 5.7% |
Asset Composition Trend (2003–2025)
This chart illustrates how Medical Developments International Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medical Developments International Limited's current assets represent 53.5% of total assets in 2025, an increase from 25.0% in 2003.
- Cash Position: Cash and equivalents constituted 26.9% of total assets in 2025, up from 8.4% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 61.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 14.2% of total assets.
Medical Developments International Limited Competitors by Total Assets
Key competitors of Medical Developments International Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Medical Developments International Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Medical Developments International Limited generates 0.59x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Medical Developments International Limited generates $ 0.14 in net profit.
Medical Developments International Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.54 | 2.74 | 3.16 |
| Quick Ratio | 3.33 | 1.82 | 2.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $27.72 Million | $ 16.59 Million | $ 17.74 Million |
Medical Developments International Limited - Advanced Valuation Insights
This section examines the relationship between Medical Developments International Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.06 |
| Latest Market Cap to Assets Ratio | 0.58 |
| Asset Growth Rate (YoY) | 12.2% |
| Total Assets | $66.40 Million |
| Market Capitalization | $38.35 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medical Developments International Limited's assets below their book value (0.58 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medical Developments International Limited's assets grew by 12.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medical Developments International Limited (2003–2025)
The table below shows the annual total assets of Medical Developments International Limited from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $66.40 Million | +12.23% |
| 2024-06-30 | $59.16 Million | -45.96% |
| 2023-06-30 | $109.49 Million | +8.02% |
| 2022-06-30 | $101.36 Million | +1.18% |
| 2021-06-30 | $100.17 Million | +5.61% |
| 2020-06-30 | $94.85 Million | +11.85% |
| 2019-06-30 | $84.80 Million | +71.15% |
| 2018-06-30 | $49.55 Million | +18.64% |
| 2017-06-30 | $41.76 Million | +1.27% |
| 2016-06-30 | $41.24 Million | +79.39% |
| 2015-06-30 | $22.99 Million | +1.90% |
| 2014-06-30 | $22.56 Million | +11.25% |
| 2013-06-30 | $20.28 Million | +5.97% |
| 2012-06-30 | $19.14 Million | +14.50% |
| 2011-06-30 | $16.71 Million | +17.57% |
| 2010-06-30 | $14.21 Million | +6.15% |
| 2009-06-30 | $13.39 Million | +1.54% |
| 2008-06-30 | $13.19 Million | +8.87% |
| 2007-06-30 | $12.12 Million | -3.07% |
| 2006-06-30 | $12.50 Million | +8.17% |
| 2005-06-30 | $11.55 Million | -7.35% |
| 2004-06-30 | $12.47 Million | +7.21% |
| 2003-06-30 | $11.63 Million | -- |